Crossmark

Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12876-024-03225-8

Published Online: 2024-04-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Chen

Zhang, Daya

Huang, Shimei

Zeng, Fan

Li, Da

Zhang, Xiaodong

Chen, Runxiang

Chen, Shiju

Wang, Jun

Bai, Feihu http://orcid.org/0000-0002-1560-6131
License Information

Text and Data Mining valid from 2024-04-12

Version of Record valid from 2024-04-12
More Information

Article History

Received: 21 November 2023

Accepted: 9 April 2024

First Online: 12 April 2024

Declarations

:

: The protocol was approved by the Clinical Ethics Committee of the Second Affiliated Hospital of Hainan Medical University and performed per Helsinki’s Declaration (approval number: LW2023113). All participants provided written informed consent for data collection and storage.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below